Opinion

Memorial Sloan Kettering Radiation Oncology – Phase II trial shows the rate of implant failure in reconstructed patients with breast cancer

Photo from Memorial Sloan Kettering Radiation Oncology/X

Apr 8, 2024, 12:28

Memorial Sloan Kettering Radiation Oncology – Phase II trial shows the rate of implant failure in reconstructed patients with breast cancer

Memorial Sloan Kettering Radiation Oncology shared on X:

“New in International Journal of Radiation Oncology, Biology, Physics: Phase II trial shows the rate of implant failure in reconstructed patients with breast cancer treated with IMRT was similar to, but not improved over, conventional, 3D-conformal radiation. Breast cancer serial MRIs may detect early capsular contracture.”

Proceed to the article.
Source: Memorial Sloan Kettering Radiation Oncology/X

Breast Cancer cancer IJROBP - The Red Journal IMRT International Journal of Radiation Oncology Memorial Sloan Kettering Radiation Oncology OncoDaily Oncology radiation oncology radiation therapy

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage